Ginkgo Bioworks (NYSE:DNA) Shares Gap Down – What’s Next?

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $12.90, but opened at $12.50. Ginkgo Bioworks shares last traded at $12.34, with a volume of 161,861 shares.

Ginkgo Bioworks Stock Down 3.2 %

The stock’s fifty day simple moving average is $9.73.

Institutional Investors Weigh In On Ginkgo Bioworks

Several institutional investors and hedge funds have recently made changes to their positions in the stock. AQR Capital Management LLC acquired a new position in shares of Ginkgo Bioworks in the 2nd quarter valued at about $3,391,000. Renaissance Technologies LLC bought a new position in shares of Ginkgo Bioworks during the 2nd quarter worth approximately $2,128,000. XTX Topco Ltd acquired a new stake in shares of Ginkgo Bioworks during the 2nd quarter worth approximately $312,000. Mackenzie Financial Corp bought a new stake in shares of Ginkgo Bioworks in the 2nd quarter valued at $251,000. Finally, Erste Asset Management GmbH bought a new position in Ginkgo Bioworks during the third quarter worth $4,075,000. Institutional investors and hedge funds own 78.63% of the company’s stock.

Ginkgo Bioworks Company Profile

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.